Om

Allakos Inc. is a biopharmaceutical company focused on the development of innovative antibody-based treatments for allergic, inflammatory, and proliferative diseases. The company's approach centers around utilizing advanced immunological research to target receptors involved in a wide range of disorders. Notably, Allakos is pioneering therapeutic solutions designed to modulate the body's immune response, potentially offering relief for conditions like eosinophilic gastritis and eosinophilic esophagitis. With its commitment to addressing areas of unmet medical need, Allakos plays a crucial role in the biopharma sector, driving research and development that may lead to significant medical advancements. By focusing on these niche yet impactful areas, Allakos Inc. contributes to broadening the scope of available treatments, thus enhancing the overall landscape of biopharmaceutical innovations. With its headquarters in the heart of biotechnology innovation, the company's efforts are part of the greater narrative of health science progression, underscoring the value of specialized medical research in the quest to improve patient outcomes globally.

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I TARGET HEALTHCARE REIT MED ENDAVU: Køb Target Healthcare REIT ($37Z) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Target Healthcare REIT, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.